0001354457-23-000333.txt : 20230502
0001354457-23-000333.hdr.sgml : 20230502
20230502133712
ACCESSION NUMBER: 0001354457-23-000333
CONFORMED SUBMISSION TYPE: 25-NSE
CONFIRMING COPY:
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20230502
DATE AS OF CHANGE: 20230502
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Intelligent Medicine Acquisition Corp.
CENTRAL INDEX KEY: 0001850051
STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770]
IRS NUMBER: 862283527
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 333-260205
BUSINESS ADDRESS:
STREET 1: 9001 BURDETTE RD.
CITY: BETHESDA
STATE: MD
ZIP: 20817
BUSINESS PHONE: 202-905-5834
MAIL ADDRESS:
STREET 1: 9001 BURDETTE RD.
CITY: BETHESDA
STATE: MD
ZIP: 20817
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: Nasdaq Stock Market LLC
CENTRAL INDEX KEY: 0001354457
IRS NUMBER: 521165937
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: One Liberty Plaza
CITY: New York
STATE: NY
ZIP: 10006
BUSINESS PHONE: 301-978-4144
MAIL ADDRESS:
STREET 1: Office of General Counsel
STREET 2: 805 King Farm Blvd.
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: The Nasdaq Stock Market LLC
DATE OF NAME CHANGE: 20060224
25-NSE
1
primary_doc.xml
X0203
0001354457
Nasdaq Stock Market LLC
0001850051
Intelligent Medicine Acquisition Corp.
333-260205
9001 Burdette Rd.
Bethesda
MD
MARYLAND
20817
202-905-5834
Class A Common Stock, warrant, and unit
17 CFR 240.12d2-2(b)
Aravind Menon
Hearings Advisor
2023-05-02
EX-99.25
2
iqmddelistreason.txt
Delisting Determination, The Nasdaq Stock Market, LLC, May 2, 2023,
Intelligent Medicine Acquisition Corp.
The Nasdaq Stock Market LLC (the Exchange) has determined to remove
from listing the Class A common stock, warrant, and unit of
Intelligent Medicine Acquisition Corp., effective at the opening of
the trading session on May 12, 2023.
Based on review of information provided by the Company, Nasdaq
Staff determined that the Company no longer qualified for listing
on the Exchange pursuant to Listing Rules 5250(f) and 5450(b)(2)(B).
The Company was notified of the Staff determination on March 30, 2023.
On April 6, 2023, the Company exercised its right to appeal the Staff
determination to a Hearings Panel (Panel) pursuant to Rule 5815. On
April 25, 2023, the Company informed the Panel that it was formally
withdrawing its appeal. The Company securities were suspended on
April 27, 2023. The Staff determination to delist the Company securities
became final on April 27, 2023.